Business Relations Table - o4.fyi ()

Anmelden Gast|Guest
Beispiel: brt.php?search=wide&s=wide&p=adjective&o=wideness

Domain-Statistiken für "lixte.com"

57
Business Relations
58
Eindeutige Domains
20
Gefundene Einträge
BR-Relations: 57
From Domain Role To Domain Path Aktionen
/weekly/newsletter.html
/story/475694/lixte-biotechnology-nasdaq-lixt-positions-lb-100-to-expand-effectiveness-of-standard-cancer-treatment/
/story/513999/lixte-biotechnology-nasdaq-lixt-bringing-first-in-class-approach-to-chemo-and-immunotherapy/
/2026/04/24/tinygemsbreaks-lixte-biotechnology-holdings-inc-nasdaq-lixt-unlocking-new-potential-in-precision-cancer-treatment/
/relationships/lixte-biotechnology-holdings-inc/
/relationships/lixte-biotechnology-holdings-inc/
/precision-oncology-is-shifting-toward-combination-strategies-ultimately-changing-how-new-therapies-are-built/
/4545070/de-la-soul-leading-mens-health-conference-at-morehouse/
/news-events/press-releases/detail/47/lixte-biotechnology-holdings-announces-new-appointment-to-board-of-directors
/news-events/press-releases/detail/41/lixte-biotechnology-holdings-compound-lb-205-reported-to-have-therapeutic-potential-for-gaucher-disease
/news-events/press-releases/detail/33/lixtes-lead-compound-lb-100-reported-to-enhance-chemotherapy-effectiveness-in-animal-models-of-liver-cancer
/news-events/press-releases/detail/33/lixtes-lead-compound-lb-100-reported-to-enhance-chemotherapy-effectiveness-in-animal-models-of-liver-cancer
/news-events/press-releases/detail/32/lixtes-lb-100-selected-as-one-of-informa-and-kantar-healths-2014-top-10-most-interesting-oncology-projects-to-watch
/news-events/press-releases/detail/28/lixte-biotechnology-holdings-inc-engages-biopharmaworks-llc-to-enhance-development-of-its-pipeline-of-novel-compounds
/news-events/press-releases/detail/26/lixte-biotechnology-holdings-inc-announces-exclusive-licensing-of-their-lead-anti-cancer-compound-lb-100-for-potential-treatment-of-hepatocellular-carcinoma-in-asia-to-taipei-medical-university
/news-events/press-releases/detail/25/lixte-completes-private-placement-of-convertible-preferred-stock
/news-events/press-releases/detail/24/lixte-biotechnology-holdings-inc-s-lead-compound-lb-100-reported-to-rapidly-improve-symptoms-in-a-rodent-model-of-depression
/news-events/press-releases/detail/23/dr-stephen-forman-joins-lixte-biotechnologys-board-of-directors
/news-events/press-releases/detail/20/lixte-biotechnologys-protein-phosphatase-2a-inhibitor-lb-100-reported-to-be-a-potentiator-of-immunotherapy-in-an-animal-model
/news-events/press-releases/detail/100/lixte-biotechnology-provides-update-on-clinical-progress-and-expanding-collaborations